HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Over the last 12 months, insiders at HCA Healthcare, Inc. have bought $0 and sold $15.54M worth of HCA Healthcare, Inc. stock.
On average, over the past 5 years, insiders at HCA Healthcare, Inc. have bought $1.07M and sold $58.96M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 325 shares for transaction amount of $64,565 was made by Elcan Patricia F () on 2022‑07‑25.
2024-05-16 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 3,204 0.0012% | $326.30 | $1.05M | +4.26% | |
2024-05-15 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 1,863 0.0007% | $326.18 | $607,673 | +2.91% | |
2024-05-09 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 6,311 0.0024% | $316.88 | $2M | +4.11% | |
2024-05-09 | Sale | Cohen Jeffrey E. | SVP-Government Relations | 1,650 0.0006% | $313.00 | $516,450 | +4.11% | |
2024-05-06 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 1,600 0.0006% | $309.00 | $494,400 | +7.16% | |
2024-05-03 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 890 0.0003% | $312.00 | $277,680 | +7.84% | |
2024-05-02 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 973 0.0004% | $312.00 | $303,576 | +6.64% | |
2024-03-20 | Sale | Wasserman Chad J | SVP and CIO | 876 0.0003% | $330.25 | $289,299 | -0.67% | |
2024-03-18 | Sale | Wasserman Chad J | SVP and CIO | 344 0.0001% | $321.97 | $110,758 | -0.05% | |
2024-02-09 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 4,262 0.0016% | $306.21 | $1.31M | +5.39% | |
2024-02-06 | Sale | RUTHERFORD BILL B | CFO and EVP | 6,000 0.0023% | $310.63 | $1.86M | +5.17% | |
2024-02-05 | Sale | Wyatt Christopher F. | SVP & Controller | 4,000 0.0016% | $312.42 | $1.25M | +3.87% | |
2024-02-05 | Sale | Mosier Sammie S | SVP & Chief Nurse Executive | 1,645 0.0006% | $312.00 | $513,240 | +3.87% | |
2024-02-02 | Sale | Wasserman Chad J | SVP and CIO | 652 0.0003% | $312.04 | $203,451 | +4.16% | |
2024-01-31 | Sale | Cuffe Michael S. | EVP and Chief Clinical Officer | 3,200 0.0012% | $306.79 | $981,734 | +5.59% | |
2024-01-31 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 3,861 0.0015% | $307.00 | $1.19M | +5.59% | |
2023-08-14 | Sale | Torres Kathryn A. | SVP-Payer Contracting & Align. | 5,204 0.0019% | $269.12 | $1.4M | +4.61% | |
2023-08-11 | Sale | Cohen Jeffrey E. | SVP-Government Relations | 1,500 0.0005% | $270.00 | $405,000 | +4.99% | |
2023-08-03 | Sale | Whalen Kathleen M | SVP & Chief Ethics Officer | 2,916 0.0011% | $270.00 | $787,320 | +3.88% | |
2023-04-28 | Sale | Akdamar Erol R | Group President | 3,500 0.0013% | $285.00 | $997,500 | -3.58% |
Wyatt Christopher F. | SVP & Controller | 37383 0.014% | $340.48 | 0 | 8 | |
Cuffe Michael S. | EVP and Chief Clinical Officer | 29624 0.0093% | $340.48 | 0 | 40 | |
Torres Kathryn A. | SVP-Payer Contracting & Align. | 19612 0.0059% | $340.48 | 0 | 20 | |
Whalen Kathleen M | SVP & Chief Ethics Officer | 9454 0.0038% | $340.48 | 0 | 13 | |
RUTHERFORD BILL B | CFO and EVP | 8448 0.0032% | $340.48 | 0 | 11 | |
Mosier Sammie S | SVP & Chief Nurse Executive | 7646 0.0029% | $340.48 | 0 | 1 | |
Cohen Jeffrey E. | SVP-Government Relations | 5185 0.0016% | $340.48 | 0 | 2 | |
Wasserman Chad J | SVP and CIO | 1576 0.0001% | $340.48 | 0 | 3 | |
HERCULES HOLDING II, LLC | 10 percent owner | 99363755 37.123% | $340.48 | 0 | 5 | |
CONNAUGHTON JOHN | director | 35331374 13.2% | $340.48 | 0 | 4 | |
Gordon Christopher R | director | 35331374 13.2% | $340.48 | 0 | 4 | |
BAIN CAPITAL INVESTORS LLC | 10 percent owner | 30003156 11.2094% | $340.48 | 0 | 4 | |
PAGLIUCA STEPHEN G | director | 15225842 5.6885% | $340.48 | 0 | 5 | |
BANK OF AMERICA CORP /DE/ | 2652364 0.9909% | $340.48 | 34 | 41 | <0.0001% | |
FRIST THOMAS F JR | 471378 0.1761% | $340.48 | 8 | 1 | +1.99% | |
FRIST PATRICIA C | 10 percent owner | 389855 0.1457% | $340.48 | 5 | 0 | +7.64% |
HAZEN SAMUEL N | CEO | 323664 0.1209% | $340.48 | 0 | 13 | |
JOHNSON R MILTON | Chairman & CEO | 298775 0.1116% | $340.48 | 0 | 6 | |
BOVENDER JACK O JR | Chairman and CEO | 263370 0.0984% | $340.48 | 0 | 1 | |
Rutledge W Paul | Group President | 263077 0.0983% | $340.48 | 0 | 4 | |
Hall Charles J | Group President | 199883 0.0747% | $340.48 | 0 | 23 | |
CAMPBELL VICTOR L | SVP-Government Affairs | 189868 0.0709% | $340.48 | 0 | 13 | |
BRACKEN RICHARD M | President and COO | 130222 0.0487% | $340.48 | 0 | 8 | |
ROYAL FRANK S | director | 97913 0.0366% | $340.48 | 0 | 2 | |
ANDERSON DAVID GWIN | SVP - Finance | 94364 0.0353% | $340.48 | 0 | 22 | |
Elcan Patricia F | 89337 0.0334% | $340.48 | 2 | 0 | +13.15% | |
WALLACE BEVERLY B | President - NewCo Business | 85160 0.0318% | $340.48 | 0 | 7 | |
STEELE JOHN M | SVP & Chief Human Res. Officer | 77734 0.029% | $340.48 | 0 | 17 | |
WILLIAMS NOEL B | SVP and CIO | 72065 0.0269% | $340.48 | 0 | 9 | |
Vallarino Juan | SVP- Employer&Payer Engagement | 61036 0.0228% | $340.48 | 1 | 13 | <0.0001% |
STEAKLEY JOSEPH N | SVP-Internal Audit Services | 56974 0.0213% | $340.48 | 0 | 13 | |
Stinnett Donald W | SVP & Controller | 52499 0.0196% | $340.48 | 0 | 8 | |
WATERMAN ROBERT A | SVP & General Counsel | 50062 0.0187% | $340.48 | 0 | 17 | |
KRAVIS HENRY R | 10 percent owner | 49200 0.0184% | $340.48 | 0 | 6 | |
KKR Millennium Fund L.P. | 10 percent owner | 49200 0.0184% | $340.48 | 0 | 6 | |
KKR PEI Investments, L.P. | 10 percent owner | 49200 0.0184% | $340.48 | 0 | 6 | |
Evans Charles Robert | President - Eastern Group | 42834 0.016% | $340.48 | 0 | 2 | |
Akdamar Erol R | Group President | 42484 0.0159% | $340.48 | 0 | 2 | |
SHALLCROSS RICHARD J | CFO - Western Group | 42310 0.0158% | $340.48 | 0 | 4 | |
Billington Phillip G | SVP-Internal Audit Services | 40652 0.0152% | $340.48 | 0 | 2 | |
ELTON ROSALYN S | SVP-Operations Finance | 39662 0.0148% | $340.48 | 0 | 4 | |
HOUSER FRANK M MD | SVP-Quality & Medical Director | 38400 0.0143% | $340.48 | 0 | 7 | |
GRINNEY JAY | President-Eastern Group | 37896 0.0142% | $340.48 | 0 | 3 | |
GEORGE V CARL | SVP-Development | 36774 0.0137% | $340.48 | 0 | 8 | |
MOORE A BRUCE JR | Group President - Service Line | 30807 0.0115% | $340.48 | 0 | 24 | |
Davis Jana Joustra | SVP - Mktg. & Corp. Affairs | 26378 0.0099% | $340.48 | 1 | 14 | <0.0001% |
LINDLER PATRICIA T | SVP - Government Programs | 26331 0.0098% | $340.48 | 0 | 6 | |
TAVENNER MARILYN B | President-Outpatient Svcs Grp | 25017 0.0093% | $340.48 | 0 | 7 | |
Paslick P. Martin | SVP and CIO | 24643 0.0092% | $340.48 | 0 | 22 | |
YUSPEH ALAN R | SVP & Chief Ethics Officer | 22656 0.0085% | $340.48 | 0 | 19 | |
HANKINS ROBERT SAMUEL JR | CFO-Outpatient Services Group | 19862 0.0074% | $340.48 | 0 | 1 | |
MEYERS GEOFFREY G | director | 19167 0.0072% | $340.48 | 1 | 0 | <0.0001% |
ROWE JOHN W | director | 18133 0.0068% | $340.48 | 1 | 0 | +33.58% |
ROTH GREG | President-Ambulatory Surgery | 15081 0.0056% | $340.48 | 0 | 1 | |
Light Jay O | director | 14167 0.0053% | $340.48 | 1 | 0 | <0.0001% |
Crudele Jeffrey T | CFO-Eastern Division | 13833 0.0052% | $340.48 | 0 | 1 | |
McManus Timothy M | Group President | 13987 0.0052% | $340.48 | 0 | 1 | |
FITZGERALD JAMES A JR | SVP-Supply Chain Operations | 13843 0.0052% | $340.48 | 0 | 3 | |
LONG T MICHAEL | director | 13378 0.005% | $340.48 | 0 | 1 | |
HATCHETT GLENDA A | director | 12650 0.0047% | $340.48 | 0 | 1 | |
Foster Jon M | EVP and COO | 10938 0.0041% | $340.48 | 0 | 20 | |
MCARTHUR JOHN H | director | 10818 0.004% | $340.48 | 0 | 1 | |
Riley Wayne Joseph | director | 10819 0.004% | $340.48 | 0 | 5 | |
HOLLIDAY CHARLES O JR | director | 8000 0.003% | $340.48 | 2 | 0 | <0.0001% |
Berres Jennifer | SVP & Chief Human Res. Officer | 7392 0.0028% | $340.48 | 0 | 4 | |
AVERHOFF MAGDALENA MD | director | 6703 0.0025% | $340.48 | 0 | 1 | |
Morgan Sandra L. | SVP-Provider Relations | 5598 0.0021% | $340.48 | 0 | 11 | |
Smith Andrea B | 2239 0.0008% | $340.48 | 1 | 0 | +0.29% | |
Morrow J William | SVP - Finance and Treasurer | 1358 0.0005% | $340.48 | 0 | 7 | |
McAlevey Michael R | SVP & Chief Legal Officer | 1110 0.0004% | $340.48 | 1 | 0 | +2.53% |
Chari Ravi S. | SVP-Clinical Excellence | 0 0% | $340.48 | 0 | 5 | |
Reiner Deborah M | SVP - Mktg. & Communications | 0 0% | $340.48 | 0 | 14 | |
Perlin Jonathan B | Pres-Clinical Operations & CMO | 0 0% | $340.48 | 0 | 30 | |
Englebright Jane D. | SVP and Chief Nursing Officer | 0 0% | $340.48 | 0 | 19 | |
Sowell Joseph A III | SVP; Chief Development Officer | 0 0% | $340.48 | 1 | 9 | <0.0001% |
The Vanguard Group | $5.67B | 6.49 | 16.99M | +0.36% | +$20.11M | 0.11 | |
BlackRock | $4.85B | 5.56 | 14.55M | +0.15% | +$7.36M | 0.11 | |
Wellington Management Company | $3.84B | 4.39 | 11.5M | +12.94% | +$439.46M | 0.65 | |
Sanders Capital Llc | $3.81B | 4.37 | 11.44M | +0.29% | +$11.01M | 6.37 | |
State Street | $2.85B | 3.27 | 8.55M | -0.23% | -$6.54M | 0.12 | |
First Eagle Investment Management | $1.5B | 1.72 | 4.5M | +0.02% | +$241,475.73 | 3.42 | |
Royal Bank of Canada | $1.47B | 1.69 | 4.41M | -2.02% | -$30.39M | 0.35 | |
Geode Capital Management | $1.3B | 1.49 | 3.9M | +2.75% | +$34.78M | 0.12 | |
Bank of America | $1.2B | 1.37 | 3.6M | +7.67% | +$85.51M | 0.12 | |
T. Rowe Price | $1.03B | 1.18 | 3.1M | -6.47% | -$71.51M | 0.13 | |
Capital World Investors | $931.34M | 1.07 | 2.79M | +57.53% | +$340.12M | 0.15 | |
JPMorgan Chase | $906.05M | 1.04 | 2.72M | -6.64% | -$64.42M | 0.08 | |
Arrowstreet Capital, Limited Partnership | $859.54M | 0.98 | 2.58M | -4.52% | -$40.66M | 0.8 | |
Morgan Stanley | $724.37M | 0.83 | 2.17M | +4.6% | +$31.84M | 0.06 | |
Longview Partners (Guernsey) LTD | $698.8M | 0.8 | 2.1M | -2.78% | -$19.98M | 4.51 | |
Northern Trust | $641.27M | 0.73 | 1.92M | -4.58% | -$30.81M | 0.11 | |
Legal & General | $557.53M | 0.64 | 1.67M | -2.02% | -$11.5M | 0.13 | |
Invesco | $553.56M | 0.63 | 1.66M | -3.56% | -$20.4M | 0.12 | |
Diamond Hill Investment Group Inc | $543.87M | 0.62 | 1.63M | -3.95% | -$22.39M | 2.23 | |
AllianceBernstein | $537.43M | 0.62 | 1.61M | -10.26% | -$61.47M | 0.19 | |
Nuveen | $519.14M | 0.59 | 1.56M | -0.72% | -$3.78M | 0.15 | |
Franklin Templeton Investments | $508.02M | 0.58 | 1.52M | +3.95% | +$19.31M | 0.15 | |
BNY Mellon | $486.15M | 0.56 | 1.46M | -1.08% | -$5.31M | 0.09 | |
Janus Henderson | $477.17M | 0.55 | 1.43M | -7.83% | -$40.54M | 0.26 | |
Fil Ltd | $471.74M | 0.54 | 1.41M | -2.29% | -$11.07M | 0.46 | |
Royal London Asset Management | $420.01M | 0.48 | 1.26M | -14.58% | -$71.69M | 1.05 | |
Ubs Asset Management Americas Inc | $390.54M | 0.45 | 1.17M | -9.32% | -$40.13M | 0.14 | |
Charles Schwab | $386.72M | 0.44 | 1.16M | +2.92% | +$10.98M | 0.09 | |
Goldman Sachs | $378.82M | 0.43 | 1.14M | -2.92% | -$11.41M | 0.07 | |
LSV Asset Management | $324.6M | 0.37 | 973,224 | -7.73% | -$27.2M | 0.67 | |
Mfn Partners Management Lp | $324.82M | 0.37 | 973,898 | 0% | +$0 | 9.91 | |
Fidelity Investments | $314.64M | 0.36 | 943,351 | -4.35% | -$14.3M | 0.02 | |
Amundi | $268.63M | 0.34 | 888,562 | +3.43% | +$8.91M | 0.11 | |
Cryder Capital Partners Llp | $292.37M | 0.34 | 876,604 | +4.23% | +$11.86M | 12.71 | |
Hotchkis & Wiley Capital Management | $288.42M | 0.33 | 864,763 | -0.78% | -$2.27M | 0.97 | |
NAOS Asset Management | $285.77M | 0.33 | 856,804 | -24.31% | -$91.76M | 2.73 | |
Lyrical Asset Management Lp | $271.83M | 0.31 | 815,010 | +1.76% | +$4.7M | 4.05 | |
Darsana Capital Partners LP | $250.15M | 0.29 | 750,000 | New | +$250.15M | 8.04 | |
Td Asset Management Inc | $240.58M | 0.28 | 721,318 | +30.38% | +$56.06M | 0.21 | |
Voya Investment Management LLC | $212.31M | 0.24 | 636,983 | +11.04% | +$21.12M | 0.24 | |
Deutsche Bank | $206.03M | 0.24 | 617,726 | +7.85% | +$15M | 0.09 | |
Swiss National Bank | $200.48M | 0.23 | 601,100 | -5.77% | -$12.27M | 0.14 | |
Nordea Investment Management Ab | $196.9M | 0.23 | 593,453 | +2.64% | +$5.07M | 0.23 | |
Macquarie Group | $188.14M | 0.22 | 564,095 | -2.95% | -$5.72M | 0.15 | |
Russell Investments Group Ltd | $184.87M | 0.21 | 554,347 | -5.33% | -$10.41M | 0.26 | |
Harris Associates | $182.86M | 0.21 | 548,266 | -75.28% | -$557.03M | 0.31 | |
Epoch Investment Partners Inc | $181.08M | 0.21 | 542,906 | +18.69% | +$28.52M | 0.81 | |
Fort Washington Investment Advisors Inc Oh | $178.65M | 0.21 | 535,628 | -0.27% | -$477,614.96 | 1.17 | |
Viking Global Investors | $176.57M | 0.2 | 529,401 | -27% | -$65.31M | 0.06 | |
Barclays | $173.36M | 0.2 | 519,773 | +5.02% | +$8.29M | 0.08 |